Osaic Holdings Portfolio holdings
AUM
$45.3B
1-Year Return
15.31%
This Quarter Return
+2.68%
1 Year Return
+15.31%
3 Year Return
+59.34%
5 Year Return
+98.42%
10 Year Return
–
AUM
$42.3B
AUM Growth
-$2.45B
(-5.5%)
Cap. Flow
-$3.31B
Cap. Flow
% of AUM
-7.83%
Top 10 Holdings %
Top 10 Hldgs %
16.64%
Holding
7,490
New
499
Increased
2,573
Reduced
3,620
Closed
296
Top Buys
| 1 |
Main Sector Rotation ETF
SECT
|
+$222M |
| 2 |
Invesco Short Term Treasury ETF
TBLL
|
+$66.4M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$59.7M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$48.8M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$46.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$396M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$276M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
Amazon
AMZN
|
+$138M |
| 5 |
VanEck Morningstar Wide Moat ETF
MOAT
|
+$85.4M |
Sector Composition
| 1 | Technology | 11.05% |
| 2 | Financials | 4.39% |
| 3 | Consumer Discretionary | 3.59% |
| 4 | Healthcare | 3.34% |
| 5 | Communication Services | 2.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5901
Cellectar Biosciences
CLRB
$16.2M
| $7.12K | ﹤0.01% |
95
+78
| +459% | +$5.84K |
|
5902
Harmony Biosciences
HRMY
$1.86B
| $7.09K | ﹤0.01% |
+235
| New | +$7.09K |
|
5903
LegalZoom.com
LZ
$1.9B
| $7.09K | ﹤0.01% |
845
-1,361
| -62% | -$11.4K |
|
5904
Envoy Medical
COCH
$27.8M
| $7.08K | ﹤0.01% |
+3,000
| New | +$7.08K |
|
|
B
5905
DELISTED
Barnes Group Inc.
B
| $7.05K | ﹤0.01% |
170
-140
| -45% | -$5.8K |
|
5906
Globavend
GVH
$8.15M
| $7.04K | ﹤0.01% |
+40
| New | +$7.04K |
|
|
TDF
5907
Templeton Dragon Fund
TDF
$292M
| $7.02K | ﹤0.01% |
875
-440
| -33% | -$3.53K |
|
5908
Mersana Therapeutics
MRSN
$35.6M
| $6.99K | ﹤0.01% |
139
-12
| -8% | -$603 |
|
5909
Galicia Financial Group
GGAL
$4.81B
| $6.97K | ﹤0.01% |
228
+69
| +43% | +$2.11K |
|
5910
A10 Networks
ATEN
$1.26B
| $6.93K | ﹤0.01% |
+500
| New | +$6.93K |
|
5911
Cooper-Standard Automotive
CPS
$667M
| $6.92K | ﹤0.01% |
+556
| New | +$6.92K |
|
5912
Surmodics
SRDX
$457M
| $6.89K | ﹤0.01% |
164
-500
| -75% | -$21K |
|
5913
UroGen Pharma
URGN
$869M
| $6.88K | ﹤0.01% |
410
-253
| -38% | -$4.25K |
|
5914
Motley Fool Next Index ETF
TMFX
$33.8M
| $6.88K | ﹤0.01% |
400
| – | – |
|
5915
Delcath Systems
DCTH
$379M
| $6.86K | ﹤0.01% |
820
+149
| +22% | +$1.25K |
|
|
SPE.PRC
5916
Special Opportunities Fund, Inc. 2.75% Convertible Preferred Stock, Series C
SPE.PRC
$63M
| $6.86K | ﹤0.01% |
295
| – | – |
|
5917
Core Scientific, Inc. Tranche 1 Warrants
CORZW
$937M
| $6.84K | ﹤0.01% |
1,517
-160
| -10% | -$722 |
|
5918
InfuSystem Holdings
INFU
$204M
| $6.83K | ﹤0.01% |
+1,000
| New | +$6.83K |
|
5919
SWK Holdings
SWKH
$176M
| $6.8K | ﹤0.01% |
505
| – | – |
|
5920
CervoMed
CRVO
$77M
| $6.76K | ﹤0.01% |
395
| – | – |
|
5921
Crexendo
CXDO
$204M
| $6.75K | ﹤0.01% |
2,143
+1,893
| +757% | +$5.96K |
|
5922
DLH Holdings
DLHC
$79.1M
| $6.75K | ﹤0.01% |
639
+210
| +49% | +$2.22K |
|
5923
Stereotaxis
STXS
$260M
| $6.73K | ﹤0.01% |
3,700
+750
| +25% | +$1.37K |
|
5924
Dare Bioscience
DARE
$28.4M
| $6.72K | ﹤0.01% |
1,667
| – | – |
|
5925
Absci
ABSI
$381M
| $6.72K | ﹤0.01% |
2,181
+1,195
| +121% | +$3.68K |
|